Secondary Erythrocytosis Produced by the Tyrosine Kinase Inhibitors Sunitinib and Sorafenib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary Erythrocytosis Produced by the Tyrosine Kinase Inhibitors Sunitinib and Sorafenib

Published:2008-08-20 Issue:24 Volume:26 Page:4047-4048
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Alexandrescu Doru T.¹,McClure Rebecca²,Farzanmehr Haleh³,Dasanu Constantin A.⁴

Affiliation:

1. Georgetown University, Washington Cancer Institute, Washington, DC

2. Department of Pathology, Washington Hospital Center, Washington, DC

3. Mayo Clinic, Anatomic and Clinical Pathology and Hematology, Rochester, MN

4. Department of Hematology-Oncology, Group Health, Seattle, WA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.18.3525

Reference3 articles.

1. Uncovering Pandora’s vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib

2. Sunitinib in Patients With Metastatic Renal Cell Carcinoma

3. Knox JJ, Figlin RA, Stadler WM, et al: The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial in North America: Safety and efficacy. J Clin Oncol 25:237s,2007, (suppl, abstr 5011)

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report;Frontiers in Oncology;2024-08-06

2. Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma;Cancer Chemotherapy and Pharmacology;2023-03-24

3. Lenvatinib-Associated Erythrocytosis;American Journal of Therapeutics;2023-03-07

4. The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study;Therapeutic Advances in Urology;2023-01

5. Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study;BMC Cancer;2022-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3